Search
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 5 of 5 items.
Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity
… 2022-07-31 2022-03-03 Issue UPDATE: April 21, 2022 – Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity Pfizer Canada ULC is recalling all lots of the prescription … and inform Canadians. Original Advisory: March 3, 2022 – Pfizer recalls Accuretic blood pressure tablets due to a …
AlertPublic advisory | 2022-04-21
COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine): New Formulation/Presentation for Use in Individuals 12 Years of Age and Older
… COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine) Issue Health products - New … COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine) for 12 Years of Age and … GmbH (Germany) Canadian Importer and Distributor: Pfizer Canada ULC * Low dead-volume syringes and/or …
AlertHealth professional risk communication | 2022-05-09
Pfizer recalls Inderal-LA (propranolol hydrochloride) capsules due to a nitrosamine impurity
… Inderal-LA 160 mg 02042274 DW8241 2023-03-31 Issue Pfizer Canada ULC is recalling all lots of Inderal-LA … your condition poses a greater health risk. Contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca … info@hc-sc.gc.ca Report a health or safety concern … 214 … Pfizer recalls Inderal-LA (propranolol hydrochloride) …
AlertPublic advisory | 2022-03-01
Health Canada safety review finds link between the use of Xeljanz and Xeljanz XR (tofacitinib) and increased risk of serious heart-related issues and cancer
… of age and have at least one cardiovascular risk factor. Pfizer, the manufacturer of the drug, conducted the trial in … this safety review in 2019, Health Canada worked with Pfizer to update the Canadian labelling for Xeljanz and … of the findings. Health Canada is working with Pfizer to evaluate the available safety information for …
AlertPublic advisory | 2022-01-12
XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection
… these safety concerns, Health Canada has worked with Pfizer Canada ULC to update the XELJANZ/XELJANZ XR CPM to … taken by Health Canada Health Canada has worked with Pfizer Canada ULC to update the Canadian Product Monograph … receiving XELJANZ/XELJANZ XR should be reported to Pfizer Canada ULC or Health Canada. Pfizer Canada ULC 17300 …
AlertHealth professional risk communication | 2022-01-12